Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Avantor
NYSE:AVTR Community
1
Narratives
written by author
0
Comments
on narratives written by author
12
Fair Values set
on narratives written by author
Create a narrative
Avantor
Popular
Undervalued
Overvalued
Avantor
AN
Analyst Price Target
Consensus Narrative from 19 Analysts
Cost Transformation And New Products Will Strengthen Future Performance
Key Takeaways Strategic cost transformation and deleveraging efforts are expected to enhance margins and profitability, aiming for significant cost savings and lower leverage. Introduction of new products and services, especially digital and AI tools, is anticipated to boost customer engagement and drive revenue growth.
View narrative
US$24.64
FV
31.0% undervalued
intrinsic discount
2.42%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
9 days ago
author updated this narrative
Your Valuation for
AVTR
Avantor
Your Fair Value
US$
Current Price
US$17.01
26.4% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-415m
8b
2015
2018
2021
2024
2025
2027
2030
Revenue US$7.8b
Earnings US$814.2m
Advanced
Set as Fair Value